Amicus Therapeutics Inc. buy UBS Group AG
Start price
02.03.23
/
50%
€12.00
Target price
02.03.24
€16.05
Performance (%)
0.83%
End price
03.03.24
€12.10
Summary
This prediction ended on 03.03.24 with a price of €12.10. During the runtime of the prediction for Amicus Therapeutics Inc. the price only changed by 0.83%. UBS_Group_AG has a follow-up prediction for Amicus Therapeutics Inc. where he still thinks Amicus Therapeutics Inc. is a Buy. UBS_Group_AG has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y |
|---|---|---|---|
| Amicus Therapeutics Inc. | -2.604% | -2.604% | -23.361% |
| iShares Core DAX® | 0.039% | 0.567% | 12.281% |
| iShares Nasdaq 100 | -4.018% | -5.554% | 23.851% |
| iShares Nikkei 225® | -2.389% | -1.434% | 8.335% |
| iShares S&P 500 | -2.115% | -2.351% | 22.061% |
Comments by UBS_Group_AG for this prediction
In the thread Amicus Therapeutics Inc. diskutieren
Amicus Therapeutics, Inc. (NASDAQ: FOLD) had its price target raised by analysts at UBS Group AG from $15.00 to $17.00. They now have a "buy" rating on the stock.
Ratings data for FOLD provided by MarketBeat
In the thread Trading Amicus Therapeutics Inc.
Die von UBS_Group_AG gewählte maximale Laufzeit wurde überschritten
Current prediction by UBS_Group_AG for Amicus Therapeutics Inc.
Amicus Therapeutics Inc.
Start price
Target price
Perf. (%)
€8.60
10.05.24
10.05.24
€17.63
10.05.25
10.05.25
11.63%
25.07.24
25.07.24
